Chelsea Szu-Tu

Chelsea Szu-Tu

Auto-generated profile, based on publicly available information

Chelsea Szu-Tu

Computational Biology and Health Genomics, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Dr. Aiguader 88, Barcelona, 08003, Spain

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
MSMichael Scherer
Michael Scherer
ISIndranil Singh
Indranil Singh
MBMartina Braun
Martina Braun
CSChelsea Szu-Tu
Chelsea Szu-Tu
MKMichael Kardorff
Michael Kardorff
LVLars Velten
Lars Velten
Summary: Current approaches to lineage tracing of stem cell clones require genetic engineering or rely on sparse somatic DNA variants, which are difficult to capture at single-cell resolution. Here, we show that targeted single-cell measurements of DNA methylation at single-CpG resolution deliver joint information about cellular differentiation state and clonal identities. We develop EPI-clone, a droplet-based method for transgene-free lineage tracing, and apply it to study hematopoiesis, capturing hundreds of clonal trajectories across almost 100,000 single-cells. Using ground-truth genetic barcodes, we demonstrate that EPI-clone accurately identifies clonal lineages throughout hematopoietic differentiation. Applied to unperturbed hematopoiesis, we describe an overall decline of clonal complexity during murine ageing and the expansion of rare low-output stem cell clones. In aged human donors, we identified expanded hematopoietic clones with and without genetic lesions, and various degrees of clonal complexity. Taken together, EPI-clone enables accurate and transgene-free single-cell lineage tracing at scale.

2 March 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
JRJulia Rühle
Julia Rühle
RFRobert Frömel
Robert Frömel
AMAina Bernal Martinez
Aina Bernal Martinez
CSChelsea Szu-Tu
Chelsea Szu-Tu
JBJoseph Bowness
Joseph Bowness
LVLars Velten
Lars Velten
Cell-state-specific gene expression programs emerge from the interplay between cis-regulatory elements (CREs), such as enhancers, and transcription factors (TFs). Massively parallel reporter assays (MPRAs) have enabled large-scale dissection of CRE design principles, but bulk approaches cannot resolve cell state-specific regulatory logic on continuous trajectories of cellular differentiation, and existing single-cell MPRAs are not readily applicable to primary cell differentiation models. Here, we developed a single-cell lentiviral Massively Parallel Reporter Assay (sc-lentiMPRA) that overcomes these limitations and enables parallel quantification of enhancer activity and cellular transcriptome. Applying sc-lentiMPRA in blood stem differentiation, we profiled the activity and specificity of ~160 fully synthetic enhancers with controlled motif composition and affinities across ~190,000 single cells. Focusing on Trp53 and Cebpa, we show that enhancers with high and low affinity motifs differ qualitatively and quantitatively in their responses to TF expression gradients. For Trp53, low-affinity motifs exhibited near-linear correlation with TF expression, whereas high-affinity motifs showed reduced sensitivity to TF levels and a potential contribution of cofactor availability. In contrast, Cebpa-associated enhancers displayed nonlinear behaviors. Together, sc-lentiMPRA establishes a powerful framework for systematically relating enhancer architecture and TF expression to regulatory output at single-cell resolution during cellular differentiation.

4 September 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
SVSibylle C Vonesch
Sibylle C Vonesch
SLShengdi Li
Shengdi Li
CTChelsea Szu Tu
Chelsea Szu Tu
BHBianca P Hennig
Bianca P Hennig
NDNikolay Dobrev
Nikolay Dobrev
LSLars M Steinmetz
Lars M Steinmetz
Through the increase in the capacity of sequencing machines massively parallel sequencing of thousands of samples in a single run is now possible. With the improved throughput and resulting drop in the price of sequencing, the cost and time for preparation of sequencing libraries have become the major bottleneck in large-scale experiments. Methods using a hyperactive variant of the Tn5 transposase efficiently generate libraries starting from cDNA or genomic DNA in a few hours and are highly scalable. For genome sequencing, however, the time and effort spent on genomic DNA isolation limits the practicability of sequencing large numbers of samples. Here, we describe a highly scalable method for preparing high quality whole-genome sequencing libraries directly from yeast cultures in less than three hours at 34 cents per sample. We skip the rate-limiting step of genomic DNA extraction by directly tagmenting yeast spheroplasts and add a nucleosome release step prior to enrichment PCR to improve the evenness of genomic coverage. Resulting libraries do not show any GC-bias and are comparable in quality to libraries processed from genomic DNA with a commercially available Tn5-based kit. We use our protocol to investigate CRISPR/Cas9 on- and off-target edits and reliably detect edited variants and shared polymorphisms between strains. Our protocol enables rapid preparation of unbiased and high-quality, sequencing-ready indexed libraries for hundreds of yeast strains in a single day at a low price. By adjusting individual steps of our workflow we expect that our protocol can be adapted to other organisms.

29 August 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
SBSergi Beneyto-Calabuig
Sergi Beneyto-Calabuig
ALAnne Kathrin Ludwig
Anne Kathrin Ludwig
JKJonas-Alexander Kniffka
Jonas-Alexander Kniffka
CSChelsea Szu-Tu
Chelsea Szu-Tu
CRChristian Rohde
Christian Rohde
LVLars Velten
Lars Velten
Inter-patient variability and the similarity of healthy and leukemic stem cells have impeded the characterization of leukemic stem cells (LSCs) in acute myeloid leukemia (AML), and their differentiation landscape. Here, we introduce CloneTracer, a novel method that adds clonal resolution to single-cell RNA-seq datasets. Applied to samples from 19 AML patients, CloneTracer revealed routes of leukemic differentiation. While residual healthy cells dominated the dormant stem cell compartment, active leukemic stem cells resembled their healthy counterpart and retained erythroid capacity. By contrast, downstream myeloid progenitors were highly aberrant and constituted the disease-defining compartment: Their gene expression and differentiation state determined both chemotherapy response and the leukemia’s ability to differentiate to transcriptomically normal monocytes. Finally, we demonstrated the potential of CloneTracer to identify surface markers mis-regulated specifically in leukemic cells by intra-patient comparisons. Taken together, CloneTracer revealed a differentiation landscape that mimics its healthy counterpart and determines biology and therapy response in AML.

14 July 2026 in Genome Biology
Verified
Journal Article
Open access
JRJulia Rühle
Julia Rühle
RFRobert Frömel
Robert Frömel
AMAina Bernal Martinez
Aina Bernal Martinez
CSChelsea Szu-Tu
Chelsea Szu-Tu
JBJoseph Bowness
Joseph Bowness
LVLars Velten
Lars Velten
Background: Cell state-specific gene expression programs emerge from the interplay between cis-regulatory elements (CREs), such as enhancers, and transcription factors (TFs). Massively parallel reporter assays (MPRAs) have enabled large-scale dissection of CRE function, but bulk approaches cannot resolve cell state specificity on continuous trajectories of cellular differentiation, and existing single-cell MPRAs are not readily applicable to primary cell differentiation models. Results: Here, we develop a single-cell lentiviral Massively Parallel Reporter Assay (sc-lentiMPRA) that overcomes these limitations and enables parallel quantification of enhancer activity and cellular transcriptome. Applying sc-lentiMPRA in blood stem differentiation, we profile the activity and specificity of ~ 160 fully synthetic enhancers with controlled motif composition and affinities across ~ 190,000 single cells. Focusing on Trp53 and Cebpa, we show that enhancers with high and low affinity motifs differ qualitatively and quantitatively in their responses to TF expression gradients. For Trp53, low-affinity motifs exhibit near-linear correlation with TF expression, whereas high-affinity motifs show reduced sensitivity to TF levels. In contrast, Cebpa-associated enhancers display non-linear behaviors. Conclusions: Together, sc-lentiMPRA establishes a powerful framework for systematically relating enhancer architecture and TF expression to regulatory output at single-cell resolution during cellular differentiation.